The stock price of Quidel Corporation (NASDAQ: QDEL), a manufacturer of diagnostic healthcare products, has seen a large 19% drop over the last ten trading days, while it is down 9% over the last five ...

A couple of months back we discussed that Quidel stock may see lower levels, based on the Trefis machine learning engine, which analyzes historical stock price movements. QDEL stock is now down 14% ...

Quidel fell last week after reporting full-year 2020 results. Counterintuitive to the drop, the company's results were quite good. Revenue in 2020 rose to $1.66 billion, up 211% from revenue in 2019.

The world is facing yet another threat from the coronavirus, as the fast-spreading omicron variant continues to gain traction. So it makes sense that companies with effective COVID-19 diagnostics ...

QuidelOrtho's (QDEL) reported weakness is concentrated in post-COVID Point of Care and the deliberate US donor-screening exit ...

Quidel's Q4 revenue and earnings dropped sharply from the prior-year period. However, the company's results topped consensus estimates. Quidel's future growth drivers include the U.S. launch of a new ...

Strategic, transformational acquisition advances Quidel’s global leadership in diagnostics “The combination with Ortho will help solidify Quidel as a leader in the diagnostics industry, bringing ...

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...

Quidel is recalling its Lyra SARS-CoV-2 Assay due to a high risk of false negative results. "False negative results may lead to delayed diagnosis or inappropriate treatment of SARS-CoV-2 that may ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the ...

The shares of medical diagnostics company Quidel Corporation (QDEL) have lost momentum over the past few months. While the company witnessed strong demand for its rapid Covid antigen testing amid ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the ...